Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Sweden Breast Cancer Group.
暂无分享,去创建一个
[1] S. T. Traweek,et al. Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. , 1993, The American journal of pathology.
[2] W. McGuire,et al. How to integrate steroid hormone receptor, flow cytometric, and other prognostic information in regard to primary breast cancer , 1993, Cancer.
[3] A. Campbell,et al. Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients. , 1992, European journal of cancer.
[4] D. Altman. Categorising continuous variables. , 1991, British Journal of Cancer.
[5] E. Lane,et al. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. , 1991, The American journal of pathology.
[6] W. Lewis,et al. Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer patients , 1990, Cancer.
[7] F. Spyratos,et al. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. , 1990, Cytometry.
[8] D. Visscher,et al. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[9] D. Visscher,et al. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. , 1989, Analytical and quantitative cytology and histology.
[10] G M Clark,et al. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. , 1989, The New England journal of medicine.
[11] L. Skoog,et al. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. , 1989, European journal of cancer & clinical oncology.
[12] A. Gown,et al. Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. , 1988, The American journal of pathology.
[13] H. Clausen,et al. Antikeratin antibodies in routine diagnostic pathology , 1988 .
[14] O. Kallioniemi,et al. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. , 1987, European journal of cancer & clinical oncology.
[15] L. Skoog,et al. Proliferative index, cytosol estrogen receptor and axillary node status as prognostic predictors in human mammary carcinoma. , 1986, Breast cancer research and treatment.
[16] L. Bobrow,et al. Monoclonal antibody to cytokeratin for use in routine histopathology. , 1984, Journal of clinical pathology.
[17] Robert C. Leif,et al. Convention on nomenclature for DNA cytometry , 1984 .
[18] K. Weber,et al. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[19] I. Christensen,et al. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.
[20] Benjamin Geiger,et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.
[21] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[22] D.,et al. Regression Models and Life-Tables , 2022 .